These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12481952)

  • 21. Commentary: science friction--complementary/alternative medicine on the stony road from opinion to evidence.
    Ernst E
    Int J Epidemiol; 2001 Jun; 30(3):531-2. PubMed ID: 11416077
    [No Abstract]   [Full Text] [Related]  

  • 22. Collaborative clinical trials: quality or quantity?
    Tannock IF
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):339-43. PubMed ID: 11173126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ISAT trial.
    Britz GW; Newell DW; West GA; Lam A
    Lancet; 2003 Feb; 361(9355):431-2; author reply 432. PubMed ID: 12573405
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence-based medicine in wound care: time for a new paradigm.
    Carter MJ; Warriner RA
    Adv Skin Wound Care; 2009 Jan; 22(1):12-6. PubMed ID: 19096278
    [No Abstract]   [Full Text] [Related]  

  • 26. Strategies sought for reducing cost, improving efficiency of clinical research.
    Mitka M
    JAMA; 2011 Jul; 306(4):364-5. PubMed ID: 21791679
    [No Abstract]   [Full Text] [Related]  

  • 27. Bias in experimental study designs: randomised controlled trials with parallel groups.
    Sedgwick P
    BMJ; 2015 Jul; 351():h3869. PubMed ID: 26187730
    [No Abstract]   [Full Text] [Related]  

  • 28. Alternatives for randomization in lifestyle intervention studies in cancer patients were not better than conventional randomization.
    Velthuis MJ; May AM; Monninkhof EM; van der Wall E; Peeters PH
    J Clin Epidemiol; 2012 Mar; 65(3):288-92. PubMed ID: 21856119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-AVID subgroup analysis.
    Goldberger JJ; Parker MA; Kadish AH
    J Am Coll Cardiol; 2001 Nov; 38(5):1586-7. PubMed ID: 11691549
    [No Abstract]   [Full Text] [Related]  

  • 30. Research funds for complementary medicine.
    Chen HY; Ma BY; Grant A
    Lancet; 2001 Jun; 357(9272):1982. PubMed ID: 11436226
    [No Abstract]   [Full Text] [Related]  

  • 31. Authorship selection in industry-sponsored publications of dermatology clinical trials.
    Tauber M; Paul C
    Br J Dermatol; 2017 Jun; 176(6):1669-1671. PubMed ID: 28303566
    [No Abstract]   [Full Text] [Related]  

  • 32. Controversies in acupuncture research: selection of controls and outcome measures in acupuncture clinical trials.
    Langevin HM; Hammerschlag R; Lao L; Napadow V; Schnyer RN; Sherman KJ
    J Altern Complement Med; 2006 Dec; 12(10):943-53. PubMed ID: 17212566
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence based medicine, RCTs and their natural enemies: the clinical pharmacologist's role.
    Eichler HG
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):1-3. PubMed ID: 11204931
    [No Abstract]   [Full Text] [Related]  

  • 34. Spine device clinical trials: design and sponsorship.
    Cher DJ; Capobianco RA
    Spine J; 2015 May; 15(5):1133-40. PubMed ID: 25637470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjustments for center in multicenter studies: an overview.
    Localio AR; Berlin JA; Ten Have TR; Kimmel SE
    Ann Intern Med; 2001 Jul; 135(2):112-23. PubMed ID: 11453711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the quality of randomized controlled trials: quality of design is not the only relevant variable.
    Berk PD; Sacks HS
    Hepatology; 1999 Nov; 30(5):1332-4. PubMed ID: 10534359
    [No Abstract]   [Full Text] [Related]  

  • 38. David Moher, MSc The CONSORT Guidelines: improving the quality of research. Consolidated Standards of Reporting Trials. Interview by Bonnie Horrigan.
    Moher D
    Altern Ther Health Med; 2002; 8(3):103-8. PubMed ID: 12017485
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of the costs of a large prevention trial.
    Urban N; Self S; Kessler L; Prentice R; Henderson M; Iverson D; Thompson D; Byar D; Insull W; Gorbach SL
    Control Clin Trials; 1990 Apr; 11(2):129-46. PubMed ID: 2161311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based complementary and alternative medicine: back to basics.
    Hammerschlag R; Zwickey H
    J Altern Complement Med; 2006 May; 12(4):349-50. PubMed ID: 16722781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.